Delivery Order SPE2DE24D0013-SPE2D625F3XSR

The U.S. Defense Department's Medical Supply Chain awarded a $3,400 firm fixed-price delivery order to Cepheid Inc., a molecular diagnostics manufacturer based in Sunnyvale, California, on September 19, 2025, with an ultimate completion date of September 26, 2025. This delivery order, issued under contract XPRS4PLEX-10, carries no set-aside designation and represents a direct procurement of diagnostic solutions from a leading provider of molecular testing technologies. The award draws from Cepheid's established federal contracting relationships supporting defense and civilian healthcare systems with point-of-care diagnostic equipment and reagents.

Cepheid holds substantial existing federal contracts with the Department of Veterans Affairs and Defense Logistics Agency, including two significant Indefinite Delivery Vehicles valued at approximately $32.8 million and $2.5 million respectively, which provide ongoing access to the company's GeneXpert diagnostic systems and molecular testing reagents. The company specializes in rapid infectious disease detection, including COVID-19, influenza, RSV, and other pathogenic conditions critical to military medical readiness and veteran healthcare delivery. This delivery order likely represents a continuation of routine diagnostic supply procurement under one of Cepheid's existing federal contract vehicles, supporting the Medical Supply Chain's operational requirements through established firm fixed-price mechanisms.